Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 41 min ago
Peer-reviewedCC BYFrontiers in oncology

Tumor-associated macrophages beyond M1/M2 in NSCLC: spatially organized programs, therapy resistance, and translational targeting

  1. 1School of Life Sciences, Henan University , , ,

Related

  1. Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia.
    Rosane M B Teles, Chaouki Benabdessalem, Jonathan Perrie +30
    Nature communicationsPeer-reviewedCC BYFull textInfectious diseaseEurope PMC
  2. Immune-metabolic-redox ecosystems define spatially organized tumor states in head and neck squamous cell carcinoma.
    K. Shukla
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  3. 1144 Spatially organized cytokine responses in malignant cells predict immunotherapy response
    Keene Lee, Mehri Monavarian, Andrey Finegersh +4
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textOncologyDOAJ
  4. The TGF-β signaling activated by cancer-associated macrophages promotes cancer stemness and Gefitinib resistance in EGFR-mutant non-small-cell lung cancer.
    Shihan Liu, Yuanyuan Yu, Sensen Hao +6
    Stem cell research & therapyPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  5. eIF4A inhibition disrupts resistance-associated translational and metabolic programs in BRAF-mutant melanoma
    A. Schcolnik-Cabrera, M. Takdenti, A. Sadr Hashemi Nejad +12
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
BibTeX
@article{wang2026tumorassociated,
  title = {{Tumor-associated macrophages beyond M1/M2 in NSCLC: spatially organized programs, therapy resistance, and translational targeting}},
  author = {Xiao-Long Wang and Ziheng Jiang and Qianqian Lu and Min Fang},
  journal = {Frontiers in oncology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13656088},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Tumor-associated macrophages beyond M1/M2 in NSCLC: spatially organized programs, therapy resistance, and translational targeting
AU  - Xiao-Long Wang
AU  - Ziheng Jiang
AU  - Qianqian Lu
AU  - Min Fang
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in oncology
UR  - https://europepmc.org/article/PMC/PMC13656088
SN  - 2234-943X
ER  -